Differential binding of H3K36me3 in G34-mutant KNS42 cells drives pediatric GBM expression signatures. Differential binding of H3K36me3 in G34-mutant KNS42.

Slides:



Advertisements
Similar presentations
BCR–ABL1 B-ALLs feature DNA methylation and expression signatures centered aroundIL2RA(CD25). BCR–ABL1 B-ALLs feature DNA methylation and expression signatures.
Advertisements

ETV1 positively regulates KIT expression through direct binding to KIT enhancers in human GIST cells and forms a positive feedback circuit in GIST oncogenesis.
Chromatin Control of Developmental Dynamics and Plasticity
Volume 20, Issue 13, Pages (September 2017)
H3K4me3 pattern association with functionally relevant genes and changes over time. H3K4me3 pattern association with functionally relevant genes and changes.
by Thomas A. Paul, Juraj Bies, Donald Small, and Linda Wolff
Volume 11, Issue 2, Pages (August 2012)
Roger B. Deal, Steven Henikoff  Developmental Cell 
Shiran Bar, Maya Schachter, Talia Eldar-Geva, Nissim Benvenisty 
Shinsuke Ohba, Xinjun He, Hironori Hojo, Andrew P. McMahon 
Volume 17, Issue 4, Pages (October 2015)
Epigenetic regulation of miR-193b in liposarcomagenesis.
G34 induces a transcriptional program linked to forebrain development and self-renewal. G34 induces a transcriptional program linked to forebrain development.
Volume 2, Issue 2, Pages (February 2008)
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas by Dong Fang, Haiyun Gan, Jeong-Heon Lee, Jing Han, Zhiquan Wang, Scott M. Riester,
Volume 32, Issue 6, Pages (March 2015)
Volume 23, Issue 1, Pages 9-22 (January 2013)
Volume 24, Issue 7, Pages e8 (August 2018)
Volume 17, Issue 6, Pages (November 2016)
Volume 56, Issue 5, Pages (December 2014)
Volume 46, Issue 1, Pages (April 2012)
Shiran Bar, Maya Schachter, Talia Eldar-Geva, Nissim Benvenisty 
Volume 42, Issue 2, Pages e5 (July 2017)
Volume 22, Issue 3, Pages (January 2018)
Volume 10, Issue 10, Pages (October 2017)
Volume 17, Issue 11, Pages (December 2016)
Volume 132, Issue 6, Pages (March 2008)
Volume 14, Issue 5, Pages (February 2016)
Volume 66, Issue 4, Pages e4 (May 2017)
Volume 10, Issue 1, Pages (January 2018)
Volume 57, Issue 4, Pages (February 2015)
Volume 21, Issue 6, Pages e10 (June 2017)
Volume 42, Issue 6, Pages (June 2011)
Volume 20, Issue 13, Pages (September 2017)
Volume 7, Issue 2, Pages (August 2010)
Volume 9, Issue 3, Pages (November 2014)
Anne Pfeiffer, Hui Shi, James M. Tepperman, Yu Zhang, Peter H. Quail 
Volume 1, Issue 3, Pages (September 2007)
Volume 65, Issue 5, Pages e8 (March 2017)
Volume 29, Issue 3, Pages (March 2016)
RNA-Seq analysis of CYR1 cells in the adaptation to acid pH.
Volume 17, Issue 3, Pages (October 2016)
Volume 20, Issue 13, Pages (September 2017)
5mC-loss/5hmC-gain loci characterize neurogenic genes up-regulated during fate commitment. 5mC-loss/5hmC-gain loci characterize neurogenic genes up-regulated.
Volume 42, Issue 1, Pages (April 2011)
(A) Western blot probing nuclear extract from wild-type (wt) and the newly generated ACF1 mutant (AcfC) embryos (0–16 h). (A) Western blot probing nuclear.
Transcriptome analysis of Setdb1Mb1 pro-B cells reveals impaired pro-B to pre-B cell transition. Transcriptome analysis of Setdb1Mb1 pro-B cells reveals.
Extended analysis of differential expression datasets.
Fig. 2 Dynamics of H3K4me3 in human early development.
The CREBBP-modulated network is enriched in signaling pathways upregulated in the light zone (LZ). The CREBBP-modulated network is enriched in signaling.
Distinct molecular and clinical correlates of H3F3A mutation subgroups
Fig. 2 Cas9/RecA-mediated in vivo gene correction of Pde6b.
EZH2 overexpression establishes a unique and conserved super-enhancer–associated transcriptional landscape. EZH2 overexpression establishes a unique and.
Integrated mRNA and microRNA expression and DNA methylation clusters.
JAK2V617F leads to 5-hmC gain in vivo that correlates with gene expression. JAK2V617F leads to 5-hmC gain in vivo that correlates with gene expression.
Transcriptional and genomic targets of EN1 in TNBC cells.
Specific DNA methylation and expression signatures associated with binding of E2A–PBX1 fusion protein. Specific DNA methylation and expression signatures.
by Leighton J. Core, Joshua J. Waterfall, and John T. Lis
SY-1425 shows similar response in RARA-high AML cell lines to APL
CREBBP loss-of-function results in gene expression repression signature. CREBBP loss-of-function results in gene expression repression signature. A–D,
Volume 17, Issue 11, Pages (December 2016)
HOXA9 and STAT5 co-occupy similar genomic regions and increase JAK/STAT signaling. HOXA9 and STAT5 co-occupy similar genomic regions and increase JAK/STAT.
G34 H3K36me3 upregulates MYCN which is selectively targetable by kinases that destabilize the protein. G34 H3K36me3 upregulates MYCN which is selectively.
DDX5 localizes to promoters of DNA replication genes and functions in the loading of RNA polymerase II onto these promoters. DDX5 localizes to promoters.
EZH2-driven lung cancer as a molecularly distinct entity.
Driver pathways and key genes in OSCC
Integrated analysis of gene expression and copy number alterations.
Transcriptional and epigenetic landscapes of RMS cell lines and primary tumors. Transcriptional and epigenetic landscapes of RMS cell lines and primary.
Characteristic gene expression patterns distinguish LCH cells from other immune cells present in LCH lesions. Characteristic gene expression patterns distinguish.
Genome-wide DNA hypomethylation associated with DNMT3A mutation in murine and human FLT3ITD AML. Human: A–C, volcano plot (A) representation of mean methylation.
Presentation transcript:

Differential binding of H3K36me3 in G34-mutant KNS42 cells drives pediatric GBM expression signatures. Differential binding of H3K36me3 in G34-mutant KNS42 cells drives pediatric GBM expression signatures. A, Sanger sequencing trace for KNS42 pediatric GBM cells reveals a heterozygous c.104G>T p.(Gly34Val) H3F3A mutation. B, Western blot analysis for mono-(me1), di-(me2), and tri-(me3) methylated histone H3 in G34-mutant KNS42 and wild-type (wt) pediatric glioma cell lines. Total H3 is used as an extracted histone loading control. C, Circos plot representing the KNS42 genome, aligned with chromosomes 1 to X running clockwise from 12 o'clock. Outer ring, H3K36me3 ChIP-Seq binding. Gray, all binding; blue, differential binding in KNS42 versus SF188. Selected differentially bound developmental transcription factors and pluripotency genes are labeled. Inner ring, DNA copy number. Green points, copy number gain; black points, normal copy number; red points, copy number loss. Single base mutations in selected genes (H3F3A:G34V and TP53:R342*) are labeled inside the circle. D, correlation plot of RNA polymerase II versus H3K36me3 for 65 differentially trimethyl-bound regions by ChIP-Seq in KNS42 cells. R2 = 0.66; P < 0.0001. E, heatmap representing a ranked list of differentially bound H3K36me3 and RNA polymerase II in G34V KNS42 versus wild-type SF188 cells, with top 20 genes listed. F, GSEA for preranked differentially bound genes identified in ChIP-Seq versus those in the integrated gene expression datasets. Top, G34 versus K27: ES = 0.86, FWER P = 0.03, FDR q = 0.03. Bottom, G34 versus wild-type: ES = 0.84, FWER P = 0.02, FDR q = 0.04. G, DAVID gene ontology analysis for preranked list of differentially bound genes identified in ChIP-Seq. Fold enrichment of processes are plotted and colored by FDR q value. H, top, mean expression of the G34 core enrichment signature in a temporal gene expression dataset of human brain development. Period 1, embryonal; periods 2–7, fetal; periods 8–12, postnatal; periods 13–15, adulthood. Bottom, heatmap representing spatial differences in G34 core enrichment signature expression in structures within embryonic and early fetal development, with highest levels mapping to the ganglionic eminences and amygdala. Lynn Bjerke et al. Cancer Discovery 2013;3:512-519 ©2013 by American Association for Cancer Research